Advances in ovulation trigger strategies.
Chorionic Gonadotropin
/ therapeutic use
Cryopreservation
Embryo Transfer
Endometrium
Female
Fertility Agents, Female
/ therapeutic use
Fertilization in Vitro
Humans
Kisspeptins
/ chemistry
Oocytes
/ metabolism
Ovarian Hyperstimulation Syndrome
/ prevention & control
Ovulation
/ physiology
Ovulation Induction
/ methods
Reproductive Techniques, Assisted
Journal
Panminerva medica
ISSN: 1827-1898
Titre abrégé: Panminerva Med
Pays: Italy
ID NLM: 0421110
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
entrez:
25
1
2019
pubmed:
25
1
2019
medline:
8
3
2019
Statut:
ppublish
Résumé
Ovulation trigger (OT) strategy is a cornerstone in modern patient-tailored in-vitro fertilization treatment, securing the optimal number of mature oocytes retrieved without compromising fertilization, embryo development and euploidy rates. Moreover, the OT strategy is taken into consideration before selecting fresh or frozen embryo transfer (freeze-all) to obtain optimal reproductive outcomes while maintaining a low risk of ovarian hyperstimulation syndrome. Several OT agents have been proposed, however, the most common agents used in modern IVF are human chorionic gonadotropin and gonadotropin-releasing hormone agonist. As no OT agent can be generally recommended for universal use, this review evaluates different OT strategies in different clinical scenarios, discussing both the biological plausibility and the clinical evidence.
Identifiants
pubmed: 30674181
pii: S0031-0808.18.03537-1
doi: 10.23736/S0031-0808.18.03537-1
doi:
Substances chimiques
Chorionic Gonadotropin
0
Fertility Agents, Female
0
Kisspeptins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM